A prospective observational study on oral administration of Ellagic Acid and Annona Muricata in patients affected by non-muscle invasive bladder cancer not undergoing maintenance after 6-week intravesical prophylaxis.
Serretta V, Berardinis E, Simonato A, Guarneri A, Dispensa N, Pavone C, Busetto GM, Del Giudice F, Sanfilippo C.
Serretta V, et al.
Urologia. 2022 Feb;89(1):49-52. doi: 10.1177/03915603211022285. Epub 2021 Jun 2.
Urologia. 2022.
PMID: 34075841
INTRODUCTION: BCG and MMC shortage and Covid-19 pandemic, more recently, limit accessibility to maintenance regimen in intravesical prophylaxis against recurrence of non-muscle invasive bladder cancer (NMIBC). Ellagic acid (EA) and Annona muricata (AM) exert antitum …
INTRODUCTION: BCG and MMC shortage and Covid-19 pandemic, more recently, limit accessibility to maintenance regimen in intravesical prophyla …